Rapport Therapeutics, Inc. Common StockRAPPNASDAQ
Loading
Total Costs & Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+129.4%
Year-over-Year Change
Total of all costs and expenses
3Y CAGR
+129.4%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
12.1x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $125.10M | +50.6% |
| 2024 | $83.06M | +129.6% |
| 2023 | $36.18M | +249.0% |
| 2022 | $10.37M | - |